Review: Clonidine is more effective than placebo for long term smoking cessation, but has side effects

Evidence-Based Medicine

Volumn 10, Issue 1, 2005, Pages 19-

  Gourlay, S G ^a   Stead, L F ^c   Benowitz, N L ^c   Bentz, Charles J ^b  

^a GENENTECH INC   (United States)

^b PROVIDENCE ST VINCENT MEDICAL CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CLONIDINE; NICOTINE; NORTRIPTYLINE; PLACEBO;

BEHAVIOR THERAPY; CIGARETTE SMOKING; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DROWSINESS; DRUG COST; DRUG EFFICACY; DRUG RESPONSE; HUMAN; LONG TERM CARE; ORTHOSTATIC HYPOTENSION; SEDATION; SHORT SURVEY; SIDE EFFECT; SMOKING CESSATION; SMOKING HABIT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TOBACCO DEPENDENCE; XEROSTOMIA;

EID: 13844317887     PISSN: 13565524     EISSN: None     Source Type: Journal    
DOI: 10.1136/ebm.10.1.19     Document Type: Short Survey

References (2)

1. Roehrick H, Gold MS. Clonidine. Adv Alcohol Subst Abuse 1987;7:1-16.
2. Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services; June 2000. http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat2.chapter.7644 (accessed Dec 1, 2004).